Brian D. Zook - 16 Jun 2026 Form 4 Insider Report for Liberty Latin America Ltd. (LILA)

Reporting relationship: MD, CHIEF ACCOUNTING OFFICER
Issuer ticker: LILA
Reported as of: 16 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jul 2026, 20:12:52 UTC
Prior SEC filing: 17 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ John M. Winter, Attorney-in-Fact

Key filing fact

Brian D. Zook filed Form 4 for Liberty Latin America Ltd. (LILA) on 17 Jul 2026.

Key facts

This page summarizes Brian D. Zook's Form 4 filing for Liberty Latin America Ltd. (LILA).
3 reported transactions and 21 derivative rows are listed below.
Accepted by SEC: 17 Jul 2026, 20:12.

Change

Previous filing in this sequence was filed on 17 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001725076 Primary reporting owner

ZOOK BRIAN D

Relationship: MD, CHIEF ACCOUNTING OFFICER
Address: 1550 WEWATTA STREET, SUITE 800, DENVER
Signature: /s/ John M. Winter, Attorney-in-Fact
Signature date: 17 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LILA transaction

Series A Preference Shares

Other

Transaction value
Shares: +4,918
Change %
Price: $0.000000^*
Shares after: 4,918
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F1

LILA transaction

Series A Preference Shares

Other

Transaction value
Shares: +140
Change %
Price: $0.000000^*
Shares after: 140
Date: 16 Jun 2026
Ownership: By IRA
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LILA transaction Derivative

Restricted Share Units P

Other

Transaction value
Shares: +2,164
Change %
Price: $0.000000^*
Shares after: 2,164
Date: 17 Jun 2026
Ownership: Direct
Underlying class: Series A Preference Shares
Underlying amount: 2,164
Exercise price
Footnotes: F3, F4

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,170
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 15,170
Exercise price: $13.03
Footnotes: F5, F6

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 31,190
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 31,190
Exercise price: $12.41
Footnotes: F5, F7

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14,847
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 14,847
Exercise price: $13.93
Footnotes: F5, F8

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 30,526
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 30,526
Exercise price: $13.63
Footnotes: F5, F9

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 26,709
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 26,709
Exercise price: $7.29
Footnotes: F5, F10

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 54,913
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 54,913
Exercise price: $7.13
Footnotes: F5, F11

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 47,666
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 47,666
Exercise price: $9.80
Footnotes: F5, F12

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 98,000
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 98,000
Exercise price: $9.60
Footnotes: F5, F13

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 23,699
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 23,699
Exercise price: $9.80
Footnotes: F5, F14

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 48,724
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 48,724
Exercise price: $9.60
Footnotes: F5, F15

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 36,386
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 36,386
Exercise price: $6.78
Footnotes: F5, F16

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 74,808
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 74,808
Exercise price: $6.56
Footnotes: F5, F17

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 23,626
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 23,626
Exercise price: $5.47
Footnotes: F5, F18

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 48,574
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 48,574
Exercise price: $5.30
Footnotes: F5, F19

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 29,303
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 29,303
Exercise price: $4.31
Footnotes: F20, F21

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 60,246
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 60,246
Exercise price: $4.24
Footnotes: F20, F22

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,082
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 27,082
Exercise price: $4.68
Footnotes: F23, F24

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 55,682
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 55,682
Exercise price: $4.54
Footnotes: F23, F25

LILA holding Derivative

Share Appreciation Rights A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 23,978
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class A Common Shares
Underlying amount: 23,978
Exercise price: $5.31
Footnotes: F26, F27

LILA holding Derivative

Share Appreciation Rights C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 49,297
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Class C Common Shares
Underlying amount: 49,297
Exercise price: $5.29
Footnotes: F26, F28

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 28 footnotes

Footnote F1

On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares.

Footnote F2

As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account.

Footnote F3

Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.

Footnote F4

The RSUs vest in full on March 15, 2027.

Footnote F5

The derivative security is fully vested.

Footnote F6

This share appreciation right award ("SAR") was previously reported as a SAR relating to 10,609 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F7

This SAR was previously reported as a SAR relating to 21,218 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F8

This SAR was previously reported as a SAR relating to 10,383 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F9

This SAR was previously reported as a SAR relating to 20,766 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F10

This SAR was previously reported as a SAR relating to 18,678 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F11

This SAR was previously reported as a SAR relating to 37,356 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F12

This SAR was previously reported as a SAR relating to 33,333 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F13

This SAR was previously reported as a SAR relating to 66,667 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F14

This SAR was previously reported as a SAR relating to 16,573 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F15

This SAR was previously reported as a SAR relating to 33,146 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F16

This SAR was previously reported as a SAR relating to 25,445 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F17

This SAR was previously reported as a SAR relating to 50,890 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F18

This SAR was previously reported as a SAR relating to 16,522 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F19

This SAR was previously reported as a SAR relating to 33,044 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F20

The SARs vest in full on March 15 2027.

Footnote F21

This SAR was previously reported as a SAR relating to 20,492 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F22

This SAR was previously reported as a SAR relating to 40,984 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F23

The SARs vest in two equal annual installments on March 15 of 2027 and 2028.

Footnote F24

This SAR was previously reported as a SAR relating to 18,939 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F25

This SAR was previously reported as a SAR relating to 37,879 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F26

The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.

Footnote F27

This SAR was previously reported as a SAR relating to 16,768 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F28

This SAR was previously reported as a SAR relating to 33,536 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

SEC remarks

The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK, and the trading symbol for the Issuer's Series A Preference Shares is LILAP.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .